TEMPERATURE CONTROLLED PHARMACEUTICAL CONTAINERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Global temperature controlled pharmaceutical containers market is estimated to be valued at USD 5.09 Bn in 2024 and is expected to reach USD 10.26 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.
Discover market dynamics shaping the industry request sample copy
Global temperature controlled pharmaceutical containers market growth is driven by rising demand for temperature-sensitive drugs and biologics due to the increasing prevalence of chronic diseases. Stringent regulations regarding the transportation of pharmaceutical products compels pharmaceutical manufacturers and logistics companies to utilize innovative temperature controlled packaging solutions. Growing focus on cold chain management of vaccines and development of next-generation temperature-controlled packaging such as intelligent & smart containers are expected to create lucrative opportunities for market players. However, high costs associated with advanced temperature controlled solutions can hamper the market growth.
Increasing Product Launches by Key Market Players
Increasing adoption of organic growth strategies such as product launches by key market players is expected to drive the market growth over the forecast period. For instance, in September 2023, Pluss Advanced Technologies (PLUSS), the phase change material technology company, announced the launch of Celsure XL Pallet Shipper series and Celsure VIP Multi-use parcel shipper series, two new temperature-controlled packaging solutions for the pharmaceutical industry, that offers a alternative to conventional gel pack solutions and expensive leased containers.
Get actionable strategies to beat competition: Get instant access to report
Growing demand for temperature-controlled packaging solutionsThe demand for temperature controlled packaging solutions for pharmaceutical products has been increasing significantly over the past few years. With more medicines and vaccines requiring strict temperature control during storage and transportation, the need for specialized temperature controlled containers and packaging has risen tremendously. This stringent requirement is driven by the fact that exposing drugs and biological products to temperatures outside their recommended range, even briefly, can potentially reduce their efficacy and potency or even render them ineffective.
To learn more about this report, request sample copy
Market Challenge – Lack of Infrastructure and Standardization in Emerging MarketsLack of adequate infrastructure and standardization can hamper the growth of the temperature controlled pharmaceutical containers market in emerging economies. While the demand for temperature sensitive drugs is increasing due to the rising income levels and awareness, lack of proper cold chain facilities hampers the last mile delivery of such products. This limits the effective distribution of biologics, vaccines and other drugs that require temperature control during transport and storage. Absence of standardized protocols for monitoring, tracking and validation of shipment conditions from manufacturing to the patient also reduces supply chain efficiency and trust in these markets.
Market Opportunity – Increasing Inorganic Growth Strategies by Key Market Players
Increasing adoption of inorganic growth strategies, such as agreement, is expected to offer lucrative growth opportunities for the market growth over the forecast period. For instance, in November 2022, Sonoco ThermoSafe, a unit of Sonoco and one of the largest global providers of temperature assurance packaging, and LATAM Cargo, an international cargo airline, announced a global lease agreement for the new Pegasus ULD temperature-controlled bulk shipping container.
Discover high revenue pocket segments and roadmap to it: Get instant access to report
Insights, By Product Type: Product innovation drives insulated shippers growthProduct Type segment is sub-segmented into insulated shippers, insulated containers, and others. Insulated shippers sub-segment is estimated to hold 43.9% of the market share in 2024 due to continuous innovations. Insulated shippers offer reliable temperature control during transit, thus, making them indispensable for transporting temperature sensitive medications and biological samples. Leading manufacturers are focusing on developing advanced insulation technologies that can withstand challenging climate conditions and extend product lifetime. For example, new vacuum insulated panels significantly reduce heat transfer, keeping contents within recommended temperature ranges for longer durations as compared to traditional materials. Some companies have also engineered shippers with improved assembly/disassembly mechanisms for reuse that eases costs and environmental impact.
Insights, By Application: Specialized cold chain infrastructure drives the frozen segment
Application segment is sub-segmented into frozen, chilled, ambient. Frozen sub-segment is estimated to hold 41.4% of the market share in 2024 as stringent regulations mandate specialized logistics for medications requiring sub-zero storage and transportation. However, developing robust cold chain infrastructure presented challenges initially especially in emerging pharma hubs. To address this issue, several logistics companies invested in centralized refrigerated warehouses, controlled atmosphere carriers and advanced facility monitoring systems. Courier fleets were upgraded with temperature mapping, GPS tracking and multi-compartment refrigeration, thus, enabling separation of doses with varying freezing requirements.
Insights, By End User: Growing Biotech Sector Catalyzes Demand from Biopharma Companies
End User segment is sub-segmented into biopharmaceutical companies, research institutes, others. Biopharmaceutical companies sub-segment is estimated to hold 54.6% of the market share in 2024, due to rising share of biologics in drug pipelines. While working on novel targets, these companies rely heavily on contract manufacturers and logistics providers for finished drug supply. Given their resource constraints and focus on R&D, outsourcing non-core operations like packaging, storage and transportation helps speed products to market. Experienced temperature-controlled packaging vendors provide compliant, cost-effective solutions tailored to each stage of clinical trials and commercialization. As biologics commercialization grows exponentially, large pharma firms also leverage specialized third-party logistics to ensure seamless supply chain execution worldwide, and this reduces investment risks. Technology alliances further help optimize packaging, refrigeration and monitoring approaches.
To learn more about this report, request sample copy
North America remains the dominant region in the global temperature controlled pharmaceutical containers market and is estimated to hold 41.2% of the market share in 2024. The U.S. accounts for the bulk of the regional market owing to a well-developed pharmaceutical industry and strong healthcare infrastructure. Major pharmaceutical companies have their headquarters located in the U.S. and have an extensive distribution network across North America that requires reliable temperature-controlled packaging solutions. Furthermore, rising healthcare expenditure in the U.S. and growing demand for biologics and specialty drugs has compelled pharmaceutical manufacturers to focus on maintaining an uninterrupted cold chain. This has boosted adoption of temperature controlled pharmaceutical containers in North America.
The Asia Pacific region is poised to be the fastest growing market for temperature controlled pharmaceutical containers during the forecast period. With improved healthcare access and a rapidly expanding middle-class population, the pharmaceutical industry in Asia Pacific countries has witnessed rampant growth. Countries like China, India and South Korea have emerged as global manufacturing hubs for pharmaceuticals and biologics. The increasing exports of medicines from these countries requires robust cold chain management, which is a key factor supporting the market growth. The presence of major global pharmaceutical firms actively engaged in manufacturing and supply in Asia Pacific boosts demand for temperature controlled pharmaceutical containers.
Temperature Controlled Pharmaceutical Containers Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 5.09 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 10.5% | 2031 Value Projection: | US$ 10.26 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Cold Chain Technologies, Va-Q-Tec AG, Pelican BioThermal Limited, SOFRIGAM GROUP, Sonoco, Inmark Packaging, Snyder Industries, ACH Foam Technologies, LLC, Cryopak Industries Inc., Saeplast, Exeltainer, OMEGA Engineering, Envirotainer Ltd, Klinge Corporation, American Aerogel Corporation |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: Temperature controlled pharmaceutical containers consists of pharmaceutical shipping containers and packaging that are designed to maintain temperature-controlled environments for medicines such as vaccines, insulin, biologics, and other drugs requiring strict temperature control during transport. These specialized containers uses various techniques like insulation, gel packs, dry ice, or powered cooling to keep medications within required temperature ranges to ensure their efficacy and safety during distribution through global supply chains.
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Credibility and Certifications
860519526
9001:2015
27001:2022
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowSelect a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
